Related Experiment Videos
Prognostic parameters for flare in systemic lupus erythematosus
M J Mirzayan1, R E Schmidt, T Witte
1Abteilung Klinische Immunologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.
Rheumatology (Oxford, England)
|January 4, 2001
Summary
Anemia and lymphopenia are key indicators for predicting future systemic lupus erythematosus (SLE) flares and disease activity. These findings aid in proactive patient management for SLE.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with unpredictable flares.
- Identifying early prognostic markers for SLE flares and disease activity is crucial for effective patient management.
Purpose of the Study:
- To identify prognostic parameters that predict future flares in patients with SLE.
- To determine predictors of SLE disease activity index (SLEDAI) over a 2-year follow-up period.
Main Methods:
- A prospective study involving 120 SLE patients over 2 years.
- Regular clinical and laboratory assessments, including SLEDAI, every 3 months.
- Correlation analysis of baseline parameters with flares and SLEDAI at 1 and 2 years.
Main Results:
- Erythrocyte sedimentation rate, anemia, and lymphopenia significantly predicted SLE flares.
- Antinuclear antibodies, anti-dsDNA antibodies, lymphopenia, anemia, and baseline SLEDAI predicted SLEDAI at 1 year.
Conclusions:
- Anemia and lymphopenia are significant predictors of both SLE flares and SLEDAI within the subsequent year.
- These hematological markers offer valuable insights for proactive monitoring and management of SLE patients.